Evofem Biosciences
EVFM
₹0.77
Share price
-2.17%
Change (1 day)
-53.71%
Change (1 year)
Categories
Operating Margin for Evofem Biosciences (EVFM)
Operating Margin as of April 2025 (TTM): -39.64%
According to Evofem Biosciences 's latest financial reports and stock price the company's current Operating Margin is -39.64%. At the end of 2023 the company had an Operating Margin of 290.90%.
Operating Margin history for Evofem Biosciences from 2021 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 290.90% | -163.9% |
| 2022 | -455.27% | -81.71% |
| 2021 | -2,488.78% | -92.2% |
| 2020 | -31,906.95% | |
| 2012 | -7,827.62% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -8,391.15% | 21,068.39% | 🇺🇸 USA |
 | -1.45% | -96.34% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.